Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals, a U.S.-based biopharma focused on GI disorders, has a Phase III‑approved P‑CAB, VOQUEZNA, for GERD and H. pylori, positioning it for commercialization in a large worldwide market.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 427
- HQ: Florham Park
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.